# Zevra Therapeutics, Inc.: Form 8-K/A, filed Feb 5, 2024

- Company: [Zevra Therapeutics, Inc.](/companies/zvra.md) (CIK 1434647)
- Form: 8-K/A
- Filed: 2024-02-05
- Accepted by EDGAR: Feb 2, 2024, 22:54 ET
- Period: 2023-11-20
- Accession: 0001437749-24-003003
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1434647/000143774924003003/zvra20240126_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1434647/000143774924003003/

## Items reported

- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1434647/000143774924003003/zvra20240126_8ka.htm

Filed Feb 5, 2024.
Source: SEC EDGAR, the filing index for accession 0001437749-24-003003. Last ingested by Listed: Oct 24, 2026, 15:08 ET. No prices; not investment advice.